Today: 20 May 2026
JPMorgan Chase Stock Today (November 22, 2025): Price, Valuation and Outlook After a Powerful Earnings Year
23 November 2025
6 mins read

JPMorgan Chase Stock Today (November 22, 2025): Price, Valuation and Outlook After a Powerful Earnings Year

JPMorgan Chase & Co. (NYSE: JPM) heads into the weekend trading just below record territory, with investors weighing stellar 2025 earnings against richer valuations and a choppy macro backdrop.


JPMorgan Chase stock today: slight dip, still near the top of its range

As of the close on Friday, November 21, 2025, JPMorgan Chase stock finished at $298.02 per share, down about 0.1% from Thursday’s $298.38 close.

  • Daily range: $292.81 – $301.68
  • Volume: roughly 11.7 million shares changed hands, indicating active trading interest.
  • 52‑week range: $202.16 (low) to $322.25 (high). At Friday’s close, JPM is about 7.5% below its 52‑week high.

With a market capitalization around $825 billion and an annualized forward dividend of $6.00 per share (about a 2.0% yield), JPMorgan remains the clear heavyweight of U.S. banking stocks.

The modest pullback on Friday follows a volatile week for U.S. equities, where intraday swings have been some of the sharpest since the spring. Yet JPM is still trading close to all‑time highs after a year marked by record earnings and strong loan and deposit growth.


How JPMorgan compares with the broader market and bank sector

Even on a strong day for stocks, JPMorgan moved a bit differently than the indexes it often helps lead.

On Friday, November 21:

  • The S&P 500 rose 1.0% to close at 6,602.99.
  • The Dow Jones Industrial Average gained 1.1%.
  • The KBW Nasdaq Bank Index (BKX), a benchmark for large U.S. banks, climbed about 1.5% to 148.14.

JPMorgan, by contrast, was basically flat to slightly down on the day, even as peer bank shares rallied. That divergence reflects two things:

  1. Outperformance earlier in the year. As of early November, JPMorgan shares were up roughly 39% over the prior 12 months, making it one of the best‑performing big bank stocks in the S&P 500. Investors may be locking in profits after a strong run.
  2. Premium valuation. With multiples now above many peers, JPM often lags on short‑term “relief rallies” when traders rotate into cheaper names across the sector.

Even so, the overall tone for U.S. equities remains constructive. U.S. equity funds just recorded a fifth straight week of net inflows, supported by robust third‑quarter earnings and optimism around AI‑driven productivity gains. That backdrop has helped lift financials broadly, with bank indexes rebounding after recent volatility.


Earnings backdrop: Q3 2025 reminded markets why JPM is the bellwether

The current share price sits on top of a very strong earnings story.

In its third‑quarter 2025 results, released on October 14:

  • Net income: about $14.4 billion, up roughly 12% year‑on‑year.
  • Earnings per share (EPS):$5.07, beating analyst expectations around $4.84–$4.85 and marking ~16% growth versus the prior year.
  • Revenue: around $47 billion, up roughly 9% year‑over‑year, powered by trading, investment banking, payments and asset management.

Key profitability and balance sheet metrics underscore how strong JPMorgan’s franchise is:

  • Return on Tangible Common Equity (ROTCE): about 20% in Q3, exceptional for a mega‑bank.
  • Common Equity Tier 1 (CET1) capital ratio: around 14.8–14.9%, comfortably above regulatory minimums and internal targets.
  • Average loans: roughly $1.4 trillion, up 7% year‑over‑year.

A Reuters summary of the quarter highlighted that trading revenues hit a record, with equities trading up more than 30% and fixed income trading up over 20%, while investment banking fees jumped 16% on a rebound in dealmaking and IPOs.

Crucially, management also raised its full‑year 2025 net interest income (NII) forecast to about $95.8 billion, up from a prior $95.5 billion estimate, reflecting the benefit of higher rates and balance‑sheet growth.

Put simply: JPMorgan is not just big; it’s currently very profitable, well‑capitalized, and still gaining share across multiple lines of business.


Valuation check: is JPMorgan Chase stock expensive at current levels?

Strong fundamentals have pushed JPMorgan’s valuation onto investors’ radar. As of Friday’s close around $298:

  • Trailing price‑to‑earnings (P/E): roughly 14.7x, based on about $20 in trailing 12‑month EPS.
  • Price‑to‑book (P/B): about 2.25x, slightly above its 12‑month average near 2.20.
  • Forward dividend yield: roughly 2.0%, based on a $6.00 forward annual payout.

From a pure numbers standpoint, JPM is not cheap:

  • The stock trades above many other large U.S. banks on both P/E and P/B measures.
  • Recent commentary on platforms like Seeking Alpha has argued that JPMorgan now sits at a premium to its own historical multiples, with some analysts suggesting investors should “wait for a correction” before buying more aggressively.Seeking Alpha+1

On the other hand, the valuation isn’t extreme when you consider:

  • The bank’s 20% ROTCE, which comfortably supports a richer multiple than many peers.
  • Its scale, diversified revenue mix and leading positions in global investment banking, payments, and asset management.
  • A consensus “Buy” rating, with an average analyst price target of about $326 per share—roughly 9–10% upside from current levels.StockAnalysis

In other words, JPMorgan Chase stock today looks fairly valued to modestly expensive, depending on your expectations for earnings growth and the economic cycle.


Macro and strategic themes driving the JPMorgan story

1. Rates, the Fed and net interest income

Higher interest rates have been a double‑edged sword for banks: boosting interest income but raising worries about credit quality and funding costs.

For now, JPMorgan appears to be navigating that trade‑off well:

  • NII guidance for 2025 has been nudged higher, not lower.
  • Credit costs are rising but remain manageable relative to earnings power, with Q3 credit costs around $3.4 billion against revenue north of $47 billion.

Markets are increasingly pricing in the possibility of a Federal Reserve rate cut as early as December, which helped fuel Friday’s broad equity rally. A slower pace of rate hikes—or eventual cuts—could compress NII over time, but it also supports economic growth and reduces recession risk, both of which benefit a bank with JPMorgan’s scale.

2. AI, technology and long‑term productivity

CEO Jamie Dimon has been outspoken about the transformational impact of artificial intelligence, recently suggesting AI could eventually shorten the workweek to three‑and‑a‑half days in developed economies.

JPMorgan’s own research has highlighted booming AI capital expenditures—projected to exceed $500 billion annually by 2026—and significant potential productivity gains across sectors. For investors, that matters because:

  • JPM is deeply embedded in AI‑related financing and capital markets, advising and lending to many of the companies driving this spending.
  • Internally, the bank is pushing AI into risk management, fraud detection, customer service and trading, which could support margins over the long run.

3. Economic resilience—and Dimon’s cautious tone

Despite geopolitical tensions, trade disputes and sticky inflation, the U.S. economy has remained surprisingly resilient, with strong consumer spending and robust corporate earnings growth in 2025.

Dimon has consistently struck a “cautiously optimistic” tone: highlighting the bank’s strong results while warning about risks from tariffs, geopolitical shocks and elevated asset prices.Reuters+1 That mix of resilience and risk is exactly what’s baked into JPMorgan’s valuation today.


Key levels and what investors should watch next

For traders and longer‑term investors following JPMorgan Chase stock, a few markers stand out:

  • Near‑term resistance: The 52‑week high at $322.25 is the obvious ceiling. A decisive break above that level on strong volume would signal a new leg higher.
  • Support zone: The low‑$290s (Friday’s intraday low was $292.81) and then the mid‑$270s, where the stock consolidated earlier in the fall, look like natural support levels based on recent trading ranges.
  • Valuation band: A P/E range of roughly 13x–15x and P/B around 2.0x–2.3x has defined the stock in recent months. A move materially above that band would likely require either stronger‑than‑expected earnings growth or a broad market re‑rating.

Looking ahead to the final weeks of 2025, market participants will be watching:

  1. Federal Reserve decisions and commentary on inflation and growth.
  2. Credit trends in consumer and commercial loan books, including delinquencies and charge‑offs.
  3. Capital returns—dividends and potential buyback pace—given JPMorgan’s strong capital position and earnings power.
  4. Any fresh signals from management on NII guidance and expense discipline as the rate environment evolves.

Bottom line on JPMorgan Chase stock

As of November 22, 2025, JPMorgan Chase stock sits in a sweet—and slightly tricky—spot:

  • The fundamentals are outstanding: double‑digit profit growth, top‑tier returns on equity, robust capital ratios and a diversified, global franchise.
  • The macro environment is supportive but noisy, with markets whipsawing on shifting rate expectations and AI‑driven optimism.
  • The valuation reflects much of that good news, trading at a premium to many peers and somewhat above JPMorgan’s own historical averages, even if analysts still see room for further upside toward the low‑$300s.

For long‑term investors who believe JPMorgan will continue to compound earnings through cycles, the stock here looks like a high‑quality core holding—though not the bargain it was earlier in the year.

For more value‑oriented or tactical buyers, recent commentary pointing to stretched valuations suggests that waiting for a deeper pullback or broader market correction before adding exposure could also be a reasonable stance.

Either way, as one of the world’s most important financial institutions—and a central player in themes like AI, digital payments and global dealmaking—JPMorgan Chase will likely remain a bellwether stock to watch into 2026.


This article is for informational purposes only and does not constitute financial, investment, or trading advice. Always do your own research and consider speaking with a qualified financial professional before making investment decisions.

Stock Market Today

  • Stock Market Today May 20: Nasdaq Rises 1.5% on Renewed Risk Appetite
    May 20, 2026, 5:43 PM EDT. The S&P 500 gained 1.08% to 7,432.97, Nasdaq rose 1.54% to 26,270.36, and Dow advanced 1.31% to 50,009.34 amid falling oil prices and easing Treasury yields. AI hardware stocks like AMD and Super Micro Computer led gains, with Nvidia up 1.3% before its earnings report. Software names Salesforce and CrowdStrike also recovered. Hasbro declined nearly 9% despite beating earnings forecasts due to cautious guidance. Investor optimism reflects hopes for an end to the U.S.-Iran conflict, lowering West Texas Intermediate crude by 5% to $99 a barrel. Nvidia's earnings beat was met with muted reaction as investors awaited stronger sales forecasts. The Motley Fool highlighted other top stock picks, noting Nvidia and Netflix's historic outperformance over the S&P 500.

Latest articles

MicroAlgo Shares Surge 40% as Quantum Release Drives MLGO Spike

MicroAlgo Shares Surge 40% as Quantum Release Drives MLGO Spike

20 May 2026
MicroAlgo shares surged 39.95% to $5.36 after the company announced a quantum image-processing algorithm, with volume reaching 9.74 million shares versus a 447,270 average. The stock hit $6.87 intraday before slipping to $5.22 after hours. No customer deals, revenue targets, or product launch dates were disclosed. Market cap stood near $66.7 million at the close.
Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

20 May 2026
Immunovant shares jumped 35.3% to $35.56 after reporting 16-week data showing its drug IMVT-1402 produced ACR20, ACR50, and ACR70 response rates of 72.7%, 54.5%, and 35.8% in difficult-to-treat rheumatoid arthritis. Roivant Sciences, its majority owner, rose 14.9%. No new safety signals were reported. The trial enrolled 170 patients, most of whom had failed two prior advanced therapies.
FuelCell Energy surges as AI-fueled rally hits again, analysts wary

FuelCell Energy surges as AI-fueled rally hits again, analysts wary

20 May 2026
FuelCell Energy shares surged 16.5% to $20.22 Wednesday, rebounding after a two-day selloff. The move tracked a 1.5% gain in the Nasdaq Composite and renewed interest in companies supplying power to AI data centers. FuelCell reported a $26.1 million quarterly loss and a declining backlog, despite higher revenue and new data-center proposals. Peers traded mixed, with Bloom Energy up and Plug Power down.
BMNR Stock Today (November 22, 2025): Why BitMine Immersion Is So Volatile After a $328 Million Profit
Previous Story

BMNR Stock Today (November 22, 2025): Why BitMine Immersion Is So Volatile After a $328 Million Profit

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Next Story

Stock Market Today 23.11.2025

Go toTop